Kenakin Terry
Biochemical Reagents and Assay Development, GlaxoSmithKline Research and Development, Research Triangle Park, North Carolina 27709, USA.
J Recept Signal Transduct Res. 2007;27(4):247-59. doi: 10.1080/10799890701509000.
This article discusses a model to describe the effects of molecules that bind to a site on the receptor separate from that of the endogenous agonist to actively produce receptor signals (direct agonism). In addition, these molecules also modify the biological responses of the endogenous agonist (either potentiation or antagonism). The effects of such compounds in high-throughput screening assays are described as well as their effects on the dose-response curves to conventional agonists.
本文讨论了一种模型,该模型用于描述与内源性激动剂作用位点不同的、能与受体上某一位点结合以主动产生受体信号的分子的作用(直接激动作用)。此外,这些分子还会改变内源性激动剂的生物学反应(增强或拮抗)。文中描述了此类化合物在高通量筛选试验中的作用,以及它们对传统激动剂剂量反应曲线的影响。